Maravai LifeSciences Holdings EBIT 2019-2024 | MRVI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Maravai LifeSciences Holdings ebit from 2019 to 2024. Ebit can be defined as earnings before interest and taxes.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Maravai LifeSciences Holdings ebit from 2019 to 2024. Ebit can be defined as earnings before interest and taxes.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$205.5B
Stryker (SYK)	$138.7B
Boston Scientific (BSX)	$121.5B
Medtronic (MDT)	$113.7B
EssilorLuxottica (ESLOY)	$104.2B
Haleon (HLN)	$48.6B
Lonza Group Ag (LZAGY)	$45.9B
ResMed (RMD)	$36.9B
Koninklijke Philips (PHG)	$29.3B
Terumo (TRUMY)	$27.8B
Zimmer Biomet Holdings (ZBH)	$21.6B
Baxter (BAX)	$20.3B
Insulet (PODD)	$16.5B
Smith & Nephew SNATS (SNN)	$13.5B
Bio-Rad Laboratories (BIO)	$9.3B
Demant (WILYY)	$9.2B
BellRing Brands (BRBR)	$7.7B
Lantheus Holdings (LNTH)	$7.3B
ICU Medical (ICUI)	$4.3B
Haemonetics (HAE)	$3.9B
TG Therapeutics (TGTX)	$3.9B
GN Store Nord (GNNDY)	$3.8B
Perrigo (PRGO)	$3.8B
Neogen (NEOG)	$3.7B
Prestige Consumer Healthcare (PBH)	$3.6B
Envista Holdings (NVST)	$3.3B
QuidelOrtho (QDEL)	$3.1B
Agios Pharmaceuticals (AGIO)	$2.6B
Green Thumb Industries (GTBIF)	$2.2B
LeMaitre Vascular (LMAT)	$2B